Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bias Against the Null Hypothesis in Retrospective Registries of Gestational Drug Exposure.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2016
Same author

The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.

Drug safety·2016
Same author

When positive studies of novel therapies are subsequently nullified: cumulative meta-analyses in preeclampsia.

Clinical and investigative medicine. Medecine clinique et experimentale·2016
Same author

Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.

Journal of clinical psychopharmacology·2015
Same author

Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.

Headache·2015
Same author

Hair cortisol as a biomarker of stress in the 2011 Libyan war.

Clinical and investigative medicine. Medecine clinique et experimentale·2015

Related Experiment Video

Updated: May 29, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Safety assessment in pediatric studies.

Gideon Koren1, Abdelbasset Elzagallaai, Fatma Etwel

  • 1The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, M5G 1X8, ON, Canada. gidiup_2000@yahoo.com

Handbook of Experimental Pharmacology
|September 2, 2011
PubMed
Summary

Establishing drug-adverse reaction links, especially in children using off-label medications, is slow. This work introduces novel clinical and laboratory methods to rapidly identify serious adverse drug reactions in pediatric populations for enhanced child safety.

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Related Experiment Videos

Last Updated: May 29, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Pediatric Pharmacology
  • Adverse Drug Reaction Detection

Background:

  • Establishing links between drugs and rare, serious adverse reactions (SARs) is a lengthy process.
  • Pediatric drug use is often off-label, leading to more erratic and limited safety evidence.
  • There is a critical need for faster methods to identify drug-associated adverse reactions in children.

Purpose of the Study:

  • To present novel methodologies for the rapid identification of serious adverse drug reactions (SARs) in pediatric populations.
  • To address the challenges of establishing drug-adverse reaction associations with limited pediatric data.
  • To enhance the timeliness of child safety assessments for pharmaceuticals.

Main Methods:

  • Description of novel pharmacoepidemiological approaches utilizing clinical data.
  • Integration of laboratory-based methods for enhanced adverse reaction detection.
  • Focus on methods applicable to off-label pediatric drug use.

Main Results:

  • The chapter details several innovative methods designed for rapid SAR identification.
  • These methods aim to overcome the limitations of traditional pharmacovigilance in pediatrics.
  • The described approaches facilitate quicker establishment of drug-adverse reaction associations.

Conclusions:

  • Novel clinical and laboratory methods offer a faster pathway to identify serious adverse drug reactions in children.
  • Accelerated detection of adverse drug reactions is crucial for improving pediatric drug safety.
  • Timely identification of drug-associated risks is essential for protecting child health.